openPR Logo
Press release

Global Epilepsy Monitoring Devices Market Set for Robust Growth, Projected to Reach USD 894.63 Million by 2033 Driven by Innovations in Wearable Technology | FMI

02-18-2025 04:39 AM CET | Health & Medicine

Press release from: Future Market Insights Inc

Epilepsy Monitoring Devices Market

Epilepsy Monitoring Devices Market

The global epilepsy monitoring devices market is on a strong growth trajectory, with projections estimating a market value of USD 523.26 million in 2023. According to recent industry reports, this market is set to grow significantly over the next decade, reaching USD 894.63 million by 2033. This represents a substantial compound annual growth rate (CAGR) of 5.5% during the forecast period.

Epilepsy, a common neurological disorder affecting millions worldwide, necessitates continuous monitoring to understand and manage seizure activity effectively. The rising elderly population, who are more susceptible to epilepsy, is a major factor influencing market dynamics. In response, the development of wearable epilepsy monitoring devices has gained traction, providing patients with convenient, portable solutions that deliver real-time data on seizures.

๐†๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ข๐ง๐ญ๐จ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Œ๐จ๐ฏ๐ž๐ฆ๐ž๐ง๐ญ๐ฌ: ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ! https://www.futuremarketinsights.com/report-sample#5245502d47422d3134333134

The wearable segment is experiencing remarkable growth, with a 15.1% increase in recent years. While advancements in wearable and AI-powered systems are reshaping the market, traditional devices such as EEG (electroencephalogram) and VEEG (video EEG) systems continue to form the backbone of epilepsy monitoring, especially in clinical settings.

Hospitals hold a substantial 45% share of the epilepsy monitoring equipment market. This is due to the advanced facilities and expertise required for diagnosing and monitoring epilepsy, often necessitating long-term observation in specialized units like Epilepsy Monitoring Units (EMU).

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ

Regionally, North America dominates the epilepsy monitoring devices market with a 39% share, attributed to the presence of leading manufacturers, favorable government initiatives, and the adoption of advanced technologies such as AI-powered devices. Meanwhile, Europe also represents a significant market, with a 29% share in 2020, bolstered by robust healthcare infrastructure and the increasing acceptance of telemedicine for epilepsy care.

The Asia Pacific region is emerging as a key player, boasting an impressive growth rate of 8.15%. This growth can be linked to rising prevalence rates of epilepsy, increased healthcare expenditures, and growing public awareness of the condition. Furthermore, the cost-effectiveness of monitoring devices is a crucial factor fueling the market's expansion in this region.

As the landscape of epilepsy care evolves, innovations in monitoring technology promise to enhance patient outcomes and accessibility. Stakeholders in the healthcare sector are encouraged to invest in research and development to meet the changing needs of patients and healthcare professionals alike.

๐‡๐ž๐ข๐ ๐ก๐ญ๐ž๐ง๐ž๐ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ญ๐ž๐ซ๐ž๐ฌ๐ญ: ๐Ž๐ฎ๐ซ ๐‚๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ƒ๐ž๐ฅ๐ข๐ฏ๐ž๐ซ๐ฌ ๐„๐ฑ๐ญ๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐š๐ง๐ ๐“๐ซ๐ž๐ง๐๐ฌ! https://www.futuremarketinsights.com/reports/epilepsy-monitoring-devices-market

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž

New players can enter the competitive environment of epilepsy monitoring equipment. Even though the market is dominated by sizable firms, fresh strategies, and advances are possible. Companies that cater to the market compete fiercely, allowing the market to be dynamic.
Companies' new tactics center around accuracy and precision. Brands are using new technologies to develop new products such as seizure sleep monitors and smartwatch seizure detection gadgets.

๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ

โ€ข Nihon Kohden has developed EEG electrodes that may aid in the prevention of cross-contamination among patients and healthcare personnel.

โ€ข Natus Medical has collaborated with Holberg to create and deploy an auto-scoring system that aids in the classification of electroencephalography (EEG).

๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ

โ€ข Nihon Kohden Corporation
โ€ข Medtronic PLC
โ€ข General Electric Company
โ€ข Koninklijke Philips N.V.
โ€ข Compumedics Limited
โ€ข Natus Medical Incorporated
โ€ข EB Neuro S.p.A.
โ€ข Cadwell Industries, Inc.
โ€ข BrainScope Company, Inc.
โ€ข LivaNova PLC

๐Ž๐ฉ๐ญ๐ข๐ฆ๐ข๐ณ๐ž ๐˜๐จ๐ฎ๐ซ ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ฒ ๐ฐ๐ข๐ญ๐ก ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ! https://www.futuremarketinsights.com/industry-analysis/diagnostic-devices

๐Š๐ž๐ฒ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ฌ ๐‚๐จ๐ฏ๐ž๐ซ๐ž๐ ๐ข๐ง ๐ญ๐ก๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ

๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ:
โ€ข Wearable Devices
โ€ข Conventional Devices

๐๐ฒ ๐„๐ง๐ ๐”๐ฌ๐ž๐ซ:
โ€ข Hospitals
โ€ข Ambulatory Surgery Centers and clinic
โ€ข Neurology Centers
โ€ข Diagnostic centers
โ€ข Home Care Settings

๐๐ฒ ๐‘๐ž๐ ๐ข๐จ๐ง:
โ€ข North America
โ€ข Latin America
โ€ข Western Europe
โ€ข Eastern Europe
โ€ข Asia Pacific Excluding Japan (APEJ)
โ€ข Japan
โ€ข The Middle East & Africa (MEA)

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐…๐Œ๐ˆ'๐ฌ ๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐Ž๐ง๐ ๐จ๐ข๐ง๐  ๐‚๐จ๐ฏ๐ž๐ซ๐š๐ ๐ž ๐จ๐ง ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ƒ๐จ๐ฆ๐š๐ข๐ง:

๐๐จ๐ซ๐ญ๐š๐›๐ฅ๐ž ๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐ƒ๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ - ๐†๐ซ๐จ๐ฐ๐ญ๐ก & ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘: https://www.futuremarketinsights.com/reports/portable-medical-devices-market

๐•๐ข๐ญ๐š๐ฅ ๐’๐ข๐ ๐ง๐ฌ ๐Œ๐จ๐ง๐ข๐ญ๐จ๐ซ๐ข๐ง๐  ๐ƒ๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ - ๐“๐ซ๐ž๐ง๐๐ฌ & ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘: https://www.futuremarketinsights.com/reports/vital-signs-monitoring-devices-market

๐“๐ซ๐š๐ง๐ฌ๐œ๐ฎ๐ญ๐š๐ง๐ž๐จ๐ฎ๐ฌ ๐Œ๐จ๐ง๐ข๐ญ๐จ๐ซ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ - ๐†๐ซ๐จ๐ฐ๐ญ๐ก, ๐ƒ๐ž๐ฆ๐š๐ง๐ & ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ“: https://www.futuremarketinsights.com/reports/transcutaneous-monitors-market

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Epilepsy Monitoring Devices Market Set for Robust Growth, Projected to Reach USD 894.63 Million by 2033 Driven by Innovations in Wearable Technology | FMI here

News-ID: 3872614 • Views: โ€ฆ

More Releases from Future Market Insights Inc

Oatmeal Market Soars, Forecast to Reach USD 11129.4 Million by 2035 Amid Health and Convenience Revolution
Oatmeal Market Soars, Forecast to Reach USD 11129.4 Million by 2035 Amid Health โ€ฆ
The global oatmeal market, valued at USD 6,378.3 million in 2025, is poised for remarkable growth, with a new market outlook forecasting it to reach USD 11,129.4 million by 2035. Driven by a robust Compound Annual Growth Rate (CAGR) of 5.7%, this expansion is fueled by a powerful convergence of consumer trends, including a heightened focus on health, the demand for convenience, and a shift toward sustainable and plant-based diets. Theโ€ฆ
Native Starch Market to Reach USD 2.9 Billion by 2035, Driven by Clean-Label and Natural Food Demand
Native Starch Market to Reach USD 2.9 Billion by 2035, Driven by Clean-Label and โ€ฆ
The global native starch market is on a robust growth trajectory, propelled by the worldwide movement toward clean-label and minimally processed ingredients. Valued at USD 1.8 billion in 2025, the market is forecasted to expand to USD 2.9 billion by 2035, with a healthy Compound Annual Growth Rate (CAGR) of 5.7%. This significant growth underscores native starch's critical role in meeting evolving consumer demands for healthier, more natural food andโ€ฆ
Microbial Seed Treatment Market to Grow at 12.8% CAGR, Reaching USD 4.47 Billion by 2035 with Sustainable Farming Boost
Microbial Seed Treatment Market to Grow at 12.8% CAGR, Reaching USD 4.47 Billion โ€ฆ
The global microbial seed treatment market is poised for significant growth, with a new market outlook forecasting a robust compound annual growth rate (CAGR) of 12.8% from 2025 to 2035. Valued at an estimated USD 1.34 billion in 2025, the market is projected to reach an impressive USD 4.47 billion by 2035, reflecting a dramatic shift towards eco-friendly and high-performance agricultural solutions. This surge is fueled by a combination ofโ€ฆ
Potash Ores Market to Reach USD 2.3 Billion by 2035, Driven by Agricultural Demand and Sustainable Practices
Potash Ores Market to Reach USD 2.3 Billion by 2035, Driven by Agricultural Dema โ€ฆ
The global potash ores market, a vital component of the agricultural and industrial sectors, is set for robust expansion, with its value projected to grow from an estimated USD 1.6 billion in 2025 to USD 2.3 billion by 2035. This represents a steady Compound Annual Growth Rate (CAGR) of 3.5%, according to a new market analysis. The consistent growth is primarily fueled by the accelerating global demand for food, whichโ€ฆ

All 5 Releases


More Releases for Epilepsy

Portable Epilepsy Monitoring Market in 2025
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Portable Epilepsy Monitoring Market- (By Product Type (Device Type (Chest Sensor, Watch Sensor, Monitors, Cameras, Mattresses and Pillows, and Others) and Service), By End User (Hospitals, Ambulatory Surgery Centres & Clinics, Neurology Centres, and Home Care Settings)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Globalโ€ฆ
Top 10 Epilepsy Companies Analysis (2024)
Epilepsy also known as seizure disorder, is a chronic noncommunicable disease that affects brain. Epilepsy affects people of all races, ethnic backgrounds, genders, and ages. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00016405/?utm_source=OpenPR&utm_medium=10129 Major Companies operating in the Epilepsy Market are: โ€ข Idexx Laboratories Inc. โ€ข PBD Biotech Ltd โ€ข Thermo Fisher Scientific Inc. โ€ข Innovative Diagnostics SAS โ€ข Neogen Corp โ€ข Enfer Labs โ€ข bioMerieux SA โ€ข Ring Biotechnology Co Ltd โ€ข Bionote Inc. โ€ข Shenzhen Bioeasy Biotechnology Co Ltd. Contact Us: If you have any queries about this report or ifโ€ฆ
Epilepsy Market: Trends, Opportunities, and Challenges
Epilepsy is a neurological disorder characterized by recurrent seizures, which are caused by abnormal electrical activity in the brain. This condition affects millions of people globally, making it one of the most common neurological disorders. As the global burden of epilepsy increases, the demand for effective treatments and solutions continues to grow. The epilepsy market is evolving rapidly, with advancements in medication, diagnostics, and therapeutic technologies. This guest post aimsโ€ฆ
Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1 Billion by 2031 โ€ฆ
The global epilepsy devices market isx experiencing a remarkable surge, poised to exceed a valuation of $1.1 billion by 2031, as revealed by the latest market analysis. According to the report released by Allied Market Research, the market was valued at $675.23 million in 2021 and is projected to grow at a CAGR of 5.1% from 2022 to 2031. ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐…๐จ๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ: https://www.alliedmarketresearch.com/request-sample/A14821 Epilepsy devices playโ€ฆ
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market - Breaking the Sei โ€ฆ
Newark, New Castle, USA: The "Epilepsy with Myoclonic-Atonic Seizures Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market: https://www.growthplusreports.com/report/epilepsy-with-myoclonic-atonic-seizures-therapeutics-market/8029 Thisโ€ฆ
Rising Instances of Pediatric Epilepsy to Pave Novel Growth Avenues in Epilepsy โ€ฆ
Owing to large scale prevalence of epilepsy cases, inclusive of pediatric epilepsy, the market for epilepsy drugs is likely to remain agile in the coming years. Prevalent amongst both male and female demographics alike, epilepsy is a critical condition that affects the brain both partially as well as in whole. Lucrative reimbursement policies, coupled with growing patient awareness about novel therapeutics are likely to reflect favorably on the growth curveโ€ฆ